Transformation by Fos Proteins Requires a C-Terminal Transactivation Domain

References

• Angel, P., M. Imagawa, R. Chiu, B. Stein, R. J. Imbra, H. J. Rahmsdorf, C. Jonat, P. Herrlich, and M. Karin. 1987. Phorbol ester-inducible genes contain a common cis element recognized by a TPA-modulated trans-acting factor. Cell 49:729–739.
   PubMed Web of Science ®Google Scholar
• Auffray, C., and H. Rougeon. 1980. Purification of mouse immunoglobulin heavy chain messenger RNAs from total myeloma tumor RNA. Eur. J. Biochem. 107:303–314.
   PubMedGoogle Scholar
• Bos, T. J., F. S. Monteclaro, F. Mitsunobu, A. R. Ball, Jr., C. H. W. Chang, T. Nishimura, and P. K. Vogt. 1990. Efficient transformation of chicken embryo fibroblasts by c-Jun requires structural modification in coding and non-coding sequences. Genes Dev. 4:1677–1687.
   PubMedGoogle Scholar
• Church, G., and W. Gilbert. 1984. Genomic sequencing. Proc. Natl. Acad. Sci. USA 81:1991–1995.
   PubMed Web of Science ®Google Scholar
• Cohen, D., and T. Curran. 1988. Fra-1: a serum-inducible, cellular immediate-early gene that encodes a fos-related antigen. Mol. Cell. Biol. 8:2063–2069.
   PubMed Web of Science ®Google Scholar
• Curran, T., G. Peters, C. Van Beveren, N. M. Teich, and I. M. Verma. 1982. FBJ murine osteosarcoma virus: identification and molecular cloning of biologically active proviral DNA. J. Virol. 44:674–682.
   PubMed Web of Science ®Google Scholar
• Diamond, M., J. N. Miner, S. K. Yoshinaga, and K. R. Yamamoto. 1990. Transcription factor interactions: selection of positive or negative regulation from a single DNA response element. Science 249:1266–1272.
   PubMed Web of Science ®Google Scholar
• Gorman, C. M., L. F. Moffatt, and B. H. Howard. 1987. Recombinant genomes which express chloramphenicol acetyl-transferase in mammalian cells. Mol. Cell. Biol. 2:1044–1051.
   Google Scholar
• Greenberg, M. E., and E. B. Ziff. 1984. Stimulation of 3T3 cells induces transcription of the c-fos protooncogene. Nature (London) 311:433–435.
   PubMed Web of Science ®Google Scholar
• Halazonetis, T. D., K. Georgopoulos, M. E. Greenberg, and P. Leder. 1988. C-jun dimerizes with itself and with c-fos, forming complexes of different DNA binding affinities. Cell 55:917–924.
   PubMed Web of Science ®Google Scholar
• Jenuwein, T., D. Muller, T. Curran, and R. Muller. 1985. Extended life span and tumorigenicity of non-established mouse connective tissue cells transformed by the fos oncogene of FBR-MuSV. Cell 41:629–637.
   PubMed Web of Science ®Google Scholar
• Jonat, C., H. J. Rahmsdorf, K.-K. Park, A. C. B. Cato, S. Gebel, H. Ponta, and P. Herrlich. 1990. Antitumor promotion and antiinflammation: down modulation of AP-1 (Fos-Jun) activity by glucocorticoid hormone. Cell 62:1189–1204.
   PubMed Web of Science ®Google Scholar
• Kakidani, H., and M. Ptashne. 1988. GAL4 activates gene expression in mammalian cells. Cell 52:161–167.
   PubMed Web of Science ®Google Scholar
• Konig, H., H. Ponta, H. J. Rahmsdorf, and P. Herrlich. 1992. Interference between pathway-specific transcription factors: glucocorticoids antagonize phorbol ester-induced AP-1 activity without altering AP-1 site occupation in vivo. EMBO J. 11: 2241–2246.
   PubMed Web of Science ®Google Scholar
• Kouzarides, T., and E. Ziff. 1989. Leucine zippers of Fos, Jun and GCN4 dictate dimerization and thereby control DNA binding. Nature (London) 340:568–571.
   PubMedGoogle Scholar
• Kovary, K., and R. Bravo. 1992. Existence of different Fos/Jun complexes during the G0-to-G1 transition and during exponential growth in mouse fibroblasts: differential role of Fos proteins. Mol. Cell. Biol. 12:5015–5023.
   PubMedGoogle Scholar
• Kovary, K., C. A. Rizzo, R. P. Ryseck, T. Noguchi, C. Rayno-schek, J.-M. Pelosin, and R. Bravo. 1991. Constitutive expression of FosB and its short form, FosB/SF, induces malignant cell transformation in Rat-1 A cells. New Biol. 3:870–879.
   PubMedGoogle Scholar
• Kruijer, W., J. A. Cooper, T. Hunter, and I. M. Verma. 1984. Platelet-derived growth factor induces rapid but transient expression of the c-fos gene and protein. Nature (London) 312: 711–713.
   PubMed Web of Science ®Google Scholar
• Kunkel, T. A., J. D. Roberts, and R. A. Zakour. 1987. Rapid and efficient site-directed mutagenesis without phenotypic selection. Methods Enzymol. 154:367–382.
   PubMed Web of Science ®Google Scholar
• Lamph, W. W., P. Wamsley, P. Sassone-Corsi, and I. M. Verma. 1988. Induction of proto-oncogene JUN/AP-1 by serum and TPA. Nature (London) 334:629–631.
   PubMed Web of Science ®Google Scholar
• Lucibello, F. C., E. P. Slater, K. U. Jooss, M. Beato, and R. Muller. 1990. Mutual transrepression of Fos and the glucocorticoid receptor: involvement of a functional domain in Fos which is absent in FosB. EMBO J. 9:2827–2834.
   PubMedGoogle Scholar
• Matrisian, L. M., P. Leroy, C. Ruhlmann, M.-C. Gesnel, and R. Breathnach. 1986. Isolation of the oncogene and epidermal growth factor-induced transin gene: complex control in rat fibroblasts. Mol. Cell. Biol. 6:858–867.
   Google Scholar
• Matsui, M., M. Tidori, Y. Konuma, N. Nomura, and R. Ishizaki. 1990. Isolation of human fos-related genes and their expression during monocyte-macrophage differentiation. Oncogene 5:249–255.
   PubMed Web of Science ®Google Scholar
• Miner, J. M., and K. R. Yamamoto. 1992. The basic region of AP-1 specifies glucocorticoid receptor activity at a composite response element. Genes Dev. 6:2491–2501.
   PubMed Web of Science ®Google Scholar
• Muller, R., R. Bravo, J. Burckhardt, and T. Curran. 1984. Induction of the c-fos gene and protein by growth factors precedes activation of c-myc. Nature (London) 312:716–719.
   PubMed Web of Science ®Google Scholar
• Mumberg, D., F. C. Lucibello, M. Schuermann, and R. Muller. 1991. Alternative splicing of fosB transcripts results in differentially expressed mRNAs encoding functionally antagonistic proteins. Genes Dev. 5:1212–1223.
   PubMedGoogle Scholar
• Nakabeppu, Y., and D. Nathans. 1991. A naturally occurring truncated form of FosB that inhibits Fos/Jun transcriptional activity. Cell 64:751–759.
   PubMed Web of Science ®Google Scholar
• Nakabeppu, Y., K. Ryder, and D. Nathans. 1988. DNA binding activities of three murine jun proteins: stimulation by fos. Cell 55:907–915.
   PubMed Web of Science ®Google Scholar
• Neuberg, M., M. Schuermann, J. B. Hunter, and R. Muller. 1989. Two functionally different regions in Fos are required for the sequence-specific DNA interaction of the Fos/Jun complex. Nature (London) 338:589–590.
   PubMedGoogle Scholar
• Nishina, H., H. Sato, T. Suzuki, M. Sato, and H. Iba. 1990. Isolation and characterization of fra-2, an additional member of the fos gene family. Proc. Natl. Acad. Sci. USA 87:3619–3623.
   PubMedGoogle Scholar
• Ransone, L. J., and I. M. Verma. 1990. Nuclear protooncogenes Fos and Jun. Annu. Rev. Cell Biol. 6:539–557.
   PubMedGoogle Scholar
• Ransone, L. J., J. Visvader, P. Sassone-Corsi, and I. M. Verma. 1989. Fos and Jun interaction: mutational analysis of the role of the leucine zipper domain of both proteins. Genes Dev. 3:770–781.
   PubMedGoogle Scholar
• Rauscher, F. J., III, D. R. Cohen, T. Curran, T. J. Bos, P. K. Vogt, D. Bohmann, R. Tjian, and B. R. Franza, Jr. 1988. Fos-associated p39 is the product of the c-jun proto-oncogene. Science 240:1010–1016.
   PubMed Web of Science ®Google Scholar
• Ryder, K., L. F. Lau, and D. Nathans. 1988. A gene activated by growth factors is related to the oncogene v-jun. Proc. Natl. Acad. Sci. USA 85:1487–1491.
   PubMed Web of Science ®Google Scholar
• Ryseck, R. P., S. I. Hirai, M. Yaniv, and R. Bravo. 1988. Transcriptional activation of c-jun during the G0/G1 transition in mouse fibroblasts. Nature (London) 334:535–537.
   PubMed Web of Science ®Google Scholar
• Sadowski, I., J. Ma, S. Triezenberg, and M. Ptashne. 1988. GAL4-VP16 is an unusually potent transcriptional activator. Nature (London) 335:563–565.
   PubMed Web of Science ®Google Scholar
• Sadowski, I., and M. Ptashne. 1989. A vector for expressing GAL4(1-147) fusions in mammalian cells. Nucleic Acids Res. 17:7539.
   PubMed Web of Science ®Google Scholar
• Sassone-Corsi, P., W. W. Lamph, M. Kamps, and I. M. Verma. 1988. Fos-associated cellular p39 is related to nuclear transcription factor AP-1. Cell 54:553–560.
   PubMed Web of Science ®Google Scholar
• Sassone-Corsi, P., L. J. Ransone, W. W. Lamph, and I. M. Verma. 1988. Direct interaction between fos and jun nuclear oncoproteins: role of the ‘leucine zipper’ domain. Nature (London) 336:692–695.
   PubMed Web of Science ®Google Scholar
• Scharfmann, R., J. H. Axelrod, and I. M. Verma. 1991. Long term in vivo expression of retrovirus-mediated gene transfer in mouse fibroblast implants. Proc. Natl. Acad. Sci. USA 88:4626–4630.
   PubMed Web of Science ®Google Scholar
• Scheurmann, M., M. Neuberg, J. B. Hunter, T. Jenuwein, R. P. Ryseck, R. Bravo, and R. Mueller. 1989. The leucine repeat motif in fos protein that mediates complex formation with jun/AP-1 is required for transformation. Cell 56:507–516.
   PubMedGoogle Scholar
• Schule, R., P. Rangarajan, S. Kliewer, L. J. Ransone, J. Bolado, N. Yang, I. M. Verma, and R. M. Evans. 1990. Functional antagonism between oncoprotein c-Jun and the glucocorticoid receptor. Cell 62:1217–1226.
   PubMed Web of Science ®Google Scholar
• Sutherland, J. A., A. Cook, A. J. Bannister, and T. Kouzarides. 1992. Conserved motifs in Fos and Jun define new class of activation domain. Genes Dev. 6:1810–1819.
   PubMedGoogle Scholar
• Triezenberg, S. J., R. C. Kingsbury, and S. L. McKnight. 1988. Functional dissection of VP16, the trans-activator of herpes simplex virus immediate early gene expression. Genes Dev. 2:718–729.
   PubMed Web of Science ®Google Scholar
• Turner, R., and R. Tjian. 1989. Leucine repeats and an adjacent DNA binding domain mediate the formation of functional cFos-cJun heterodimers. Science 243:1689–1694.
   PubMed Web of Science ®Google Scholar
• Van Beveren, C., S. Enami, T. Curran, and I. M. Verma. 1984. FBR murine osteosarcoma virus. II. Nucleotide sequence of the provirus reveals that the genome contains sequences acquired from two cellular genes. Virology 135:229–243.
   PubMed Web of Science ®Google Scholar
• Wisdom, R., J. Yen, D. Rashid, and I. M. Verma. 1992. Transformation by FosB requires a trans-activation domain missing in FosB2 that can be substituted by heterologous activation domains. Genes Dev. 6:667–675.
   PubMed Web of Science ®Google Scholar
• Wisdom, R., and I. M. Verma. 1990. Revertants of v-fos-transformed rat fibroblasts: suppression of transformation is dominant. Mol. Cell. Biol. 10:5626–5633.
   PubMedGoogle Scholar
• Wisdom, R., and I. M. Verma. 1993. Proto-oncogene FosB: the amino terminus encodes a regulatory function required for transformation. Mol. Cell. Biol. 13:2635–2643.
   PubMed Web of Science ®Google Scholar
• Yang-Yen, H.-F., J.-C. Chambard, Y.-L. Sun, T. Smeal, T. J. Schmidt, J. Drouin, and M. Karin. 1990. Transcriptional interference between c-Jun and the glucocorticoid receptor: mututal inhibition of DNA binding due to direct protein-protein interaction. Cell 62:1205–1215.
   PubMed Web of Science ®Google Scholar
• Yen, J., R. Wisdom, I. Tratner, and I. M. Verma. 1991. An alternative spliced form of FosB is a negative regulator of transcriptional activation and transformation by Fos proteins. Proc. Natl. Acad. Sci. USA 88:5077–5081.
   PubMedGoogle Scholar
• Yoshida, T., Y. Shindo, K. Ohta, and H. Iba. 1989. Identification of a small region of the v-fos gene product that is sufficient for transforming potential and growth stimulating activity. Oncogene Res. 5:79–89.
   PubMedGoogle Scholar
• Zerial, M., L. Toschi, R.-P. Ryseck, M. Schuermann, R. Muller, and R. Bravo. 1989. The product of a novel growth factor activated gene, fosB, interacts with jun proteins enhancing their DNA binding activity. EMBO J. 8:805–813.
   PubMed Web of Science ®Google Scholar